SCHEMBL3432756

SCHEMBL3432756

COC(=O)/C=C/c1ccc(C2CCCN2CCn2cc(Br)c(C)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 5/20 0.52
▸ KCNH2 Q12809 1/20 0.47
▸ OPRM1 P35372 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KDM1A O60341 4/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ TYR P14679 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ NR1H4 Q96RI1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780404 1.00 HDAC1 (0.52) HDAC1KCNH2OPRM1OPRK1HTT
SCHEMBL1780403 1.00 HDAC1 (0.52) HDAC1KCNH2OPRM1OPRK1HTT
SCHEMBL1780400 1.00 HDAC1 (0.52) HDAC1KCNH2OPRM1OPRK1HTT
SCHEMBL1778049 0.92 HDAC1 (0.61) HDAC1KCNH2KDM1AHDAC8HDAC6
SCHEMBL1778045 0.92 HDAC1 (0.61) HDAC1KCNH2KDM1AHDAC8HDAC6
SCHEMBL3411827 0.92 HDAC1 (0.61) HDAC1KCNH2KDM1AHDAC8HDAC6
SCHEMBL1778047 0.92 HDAC1 (0.61) HDAC1KCNH2KDM1AHDAC8HDAC6
SCHEMBL3432137 0.84 HDAC1 (0.50) HDAC1KCNH2OPRM1OPRK1HTT
SCHEMBL1780445 0.84 HDAC1 (0.50) HDAC1KCNH2OPRM1OPRK1HTT
SCHEMBL1780451 0.84 HDAC1 (0.50) HDAC1KCNH2OPRM1OPRK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2260020-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B Novartis AG (CH) 2010-12-15 — — EP disclosed
WO-2009118305-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B NOVARTIS AG (CH) 2009-10-01 — — WO disclosed
Send feedback